Worth NF - Search Results

1

Nesprin-1 and -2 are involved in the pathogenesis of Emery Dreifuss muscular dystrophy and are critical for nuclear envelope integrity.

Zhang Q, Bethmann C, Worth NF, Davies JD, Wasner C, Feuer A, Ragnauth CD, Yi Q, Mellad JA, Warren DT, Wheeler MA, Ellis JA, Skepper JN, Vorgerd M, Schlotter-Weigel B, Weissberg PL, Roberts RG, Wehnert M, Shanahan CM. Zhang Q, et al. Among authors: worth nf. Hum Mol Genet. 2007 Dec 1;16(23):2816-33. doi: 10.1093/hmg/ddm238. Epub 2007 Aug 29. Hum Mol Genet. 2007. PMID: 17761684

2

Nesprin-2 is a multi-isomeric protein that binds lamin and emerin at the nuclear envelope and forms a subcellular network in skeletal muscle.

Zhang Q, Ragnauth CD, Skepper JN, Worth NF, Warren DT, Roberts RG, Weissberg PL, Ellis JA, Shanahan CM. Zhang Q, et al. Among authors: worth nf. J Cell Sci. 2005 Feb 15;118(Pt 4):673-87. doi: 10.1242/jcs.01642. Epub 2005 Jan 25. J Cell Sci. 2005. PMID: 15671068

3

Vascular smooth muscle cell phenotypic modulation in culture is associated with reorganisation of contractile and cytoskeletal proteins.

Worth NF, Rolfe BE, Song J, Campbell GR. Worth NF, et al. Cell Motil Cytoskeleton. 2001 Jul;49(3):130-45. doi: 10.1002/cm.1027. Cell Motil Cytoskeleton. 2001. PMID: 11668582

4

Rho expression and activation in vascular smooth muscle cells.

Worth NF, Campbell GR, Campbell JH, Rolfe BE. Worth NF, et al. Cell Motil Cytoskeleton. 2004 Nov;59(3):189-200. doi: 10.1002/cm.20036. Cell Motil Cytoskeleton. 2004. PMID: 15468163

5

Heterogeneous distribution of isoactins in cultured vascular smooth muscle cells does not reflect segregation of contractile and cytoskeletal domains.

Song J, Worth NF, Rolfe BE, Campbell GR, Campbell JH. Song J, et al. Among authors: worth nf. J Histochem Cytochem. 2000 Nov;48(11):1441-52. doi: 10.1177/002215540004801101. J Histochem Cytochem. 2000. PMID: 11036087

6

A role for rho in smooth muscle phenotypic regulation.

Worth NF, Campbell GR, Rolfe BE. Worth NF, et al. Ann N Y Acad Sci. 2001 Dec;947:316-22. doi: 10.1111/j.1749-6632.2001.tb03955.x. Ann N Y Acad Sci. 2001. PMID: 11795282

7

Rho and vascular disease.

Rolfe BE, Worth NF, World CJ, Campbell JH, Campbell GR. Rolfe BE, et al. Among authors: worth nf. Atherosclerosis. 2005 Nov;183(1):1-16. doi: 10.1016/j.atherosclerosis.2005.04.023. Epub 2005 Jun 27. Atherosclerosis. 2005. PMID: 15982657 Review.

8

Leukaemia inhibitory factor retards the progression of atherosclerosis.

Rolfe BE, Stamatiou S, World CJ, Brown L, Thomas AC, Bingley JA, Worth NF, Campbell JH. Rolfe BE, et al. Among authors: worth nf. Cardiovasc Res. 2003 Apr 1;58(1):222-30. doi: 10.1016/s0008-6363(02)00832-5. Cardiovasc Res. 2003. PMID: 12667965

9

S18886, a selective TP receptor antagonist, inhibits development of atherosclerosis in rabbits.

Worth NF, Berry CL, Thomas AC, Campbell JH. Worth NF, et al. Atherosclerosis. 2005 Nov;183(1):65-73. doi: 10.1016/j.atherosclerosis.2005.02.034. Epub 2005 Jun 9. Atherosclerosis. 2005. PMID: 15950232

10

Engineering pro-angiogenic peptides using stable, disulfide-rich cyclic scaffolds.

Chan LY, Gunasekera S, Henriques ST, Worth NF, Le SJ, Clark RJ, Campbell JH, Craik DJ, Daly NL. Chan LY, et al. Among authors: worth nf. Blood. 2011 Dec 15;118(25):6709-17. doi: 10.1182/blood-2011-06-359141. Epub 2011 Oct 28. Blood. 2011. PMID: 22039263 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters